Results for tag: "Glaucoma Drainage Devices"

Within the optical healthcare field, the market for glaucoma drainage devices encompasses a variety of medical apparatus designed to alleviate intraocular pressure (IOP) in patients suffering from glaucoma. These devices consist of microscopic shunts or valves that facilitate the drainage of aqueous humor, the fluid inside the eye whose improper regulation can lead to the increased pressure responsible for glaucoma. The treatment aims to prevent further optic nerve damage and preserve the patient's vision. The necessity for such drainage devices arises in cases where conventional therapies, such as medications or laser treatments, fail to adequately control IOP. Glaucoma drainage devices are often considered when the disease progresses to a more advanced stage or when patients exhibit a resistance to first-line treatment options. Ophthalmologists and eye surgeons employ these devices, tailoring their use to match the patient's specific type of glauocolma and the severity of their case. Technological advancements continuously influence the development of these devices, focusing on improving biocompatibility, reducing post-operative complications, and enhancing long-term efficacy. Among the companies specializing in the glaucoma drainage devices market are Allergan, PLC, implanted with their well-known brand—Ahmed Glaucoma Valve; New World Medical, which produces the Baerveldt Glaucoma Implant; Glaukos Corporation, known for their iStent technology; and Mölnlycke Health Care, which markets several drainage implants designed for use in various glaucoma surgeries. These companies are integral Show Less Read more